GlaxoSmithKline PLC Director/PDMR Shareholding (6475D)
February 20 2020 - 9:00AM
UK Regulatory
TIDMGSK
RNS Number : 6475D
GlaxoSmithKline PLC
20 February 2020
GlaxoSmithKline plc (the ' Company ')
Conditional Share Awards and Shares withheld or sold to meet tax
liabilities
This notification sets out details of the vesting of awards made
in 2017 under the GlaxoSmithKline Share Value Plan and the
subsequent sale of Ordinary Shares and American Depositary Shares
('ADSs') to meet tax liabilities arising on the vesting. The
awards, which were conditional on continued employment with the
GlaxoSmithKline group, vested on 17 February 2020 (for awards over
Ordinary Shares) and 18 February 2020 (for awards over ADSs).
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms D Conrad
==== ======================================== =================================================
b) Position/status SVP, Human Resources
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP0.00 11,060
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-02-17
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms D Conrad
==== ======================================= ======================================================
b) Position/status SVP, Human Resources
==== ======================================= ======================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= ======================================================
b) Nature of the Following the vesting of Ordinary Shares
transaction awarded in 2017 under the Company's Share
Value Plan, Ms Conrad received a cash amount
of GBP184,000 (less applicable tax withholding)
which is equal to the market value of the
number of Ordinary Shares which would otherwise
have been transferred to her.
==== ======================================= ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================== =======================
GBP16.619 11,060
======================================================================= =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== ==============================
e) Date of the transaction 2020-02-18
==== ======================================= ======================================================
f) Place of the N/A
transaction
==== ======================================= ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr J Ford
==== ======================================== ==============================================
b) Position/status SVP & General Counsel
==== ======================================== ==============================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==============================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== ==============================================
b) Nature of the The vesting of ADSs awarded in 2017 under
transaction the Company's Share Value Plan.
==== ======================================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== =================== ======================
$0.00 6,320
=================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ==================================================
e) Date of the transaction 2020-02-18
==== ======================================== ==============================================
f) Place of the N/A
transaction
==== ======================================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr J Ford
==== ======================================== ==============================================
b) Position/status SVP & General Counsel
==== ======================================== ==============================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==============================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== ==============================================
b) Nature of the The sale of ADSs to meet tax liabilities
transaction on the vesting of awards granted in 2017
under the Company's Share Value Plan.
==== ======================================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== =================== ======================
$43.544 2,971
=================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ==================================================
e) Date of the transaction 2020-02-18
==== ======================================== ==============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms S Jackson
==== ======================================== =================================================
b) Position/status SVP, Global Communications & CEO Office
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP0.00 13,070
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-02-17
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms S Jackson
==== ======================================= ===================================================
b) Position/status SVP, Global Communications & CEO Office
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= ===================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on the vesting of awards granted
in 2017 under the Company's Share Value
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= =====================
GBP16.619 6,143
====================================================================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================================================== ============================
e) Date of the transaction 2020-02-17
==== ======================================= ===================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Mr D Jackson
==== ======================================== =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
& CEO Office)
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =====================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
GBP0.00 3,810
===================================================================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ================================
e) Date of the transaction 2020-02-17
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr D Jackson
==== ======================================= =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
& CEO Office)
==== ======================================= =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= =====================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on the vesting of awards granted
in 2017 under the Company's Share Value
Plan.
==== ======================================= =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================== ======================
GBP16.619 1,791
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2020-02-17
==== ======================================= =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr R Simard
==== ======================================== =================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP0.00 11,060
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-02-17
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr R Simard
==== ======================================= ===================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= ===================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on the vesting of awards granted
in 2017 under the Company's Share Value
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= =====================
GBP16.619 5,199
====================================================================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================================================== ============================
e) Date of the transaction 2020-02-17
==== ======================================= ===================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms D Waterhouse
==== ======================================== =================================================
b) Position/status CEO of ViiV Healthcare
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP0.00 15,160
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-02-17
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms D Waterhouse
==== ======================================= ===================================================
b) Position/status CEO of ViiV Healthcare
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= ===================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on the vesting of awards granted
in 2017 under the Company's Share Value
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= =====================
GBP16.619 7,126
====================================================================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================================================== ============================
e) Date of the transaction 2020-02-17
==== ======================================= ===================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms V Whyte
==== ======================================== =================================================
b) Position/status Company Secretary
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the The vesting of Ordinary Shares awarded
transaction in 2017 under the Company's Share Value
Plan.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP0.00 11,060
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-02-17
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms V Whyte
==== ======================================= ===================================================
b) Position/status Company Secretary
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================= ===================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on the vesting of awards granted
in 2017 under the Company's Share Value
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= =====================
GBP16.619 5,199
====================================================================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================================================== ============================
e) Date of the transaction 2020-02-17
==== ======================================= ===================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= ===================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHXBLFLBLLZBBV
(END) Dow Jones Newswires
February 20, 2020 09:00 ET (14:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
